217 related articles for article (PubMed ID: 34082122)
1. Robustness of aerosol delivery of amikacin liposome inhalation suspension using the eFlow® Technology.
Li Z; Perkins W; Cipolla D
Eur J Pharm Biopharm; 2021 Sep; 166():10-18. PubMed ID: 34082122
[TBL] [Abstract][Full Text] [Related]
2. Characterization of nebulized liposomal amikacin (Arikace) as a function of droplet size.
Li Z; Zhang Y; Wurtz W; Lee JK; Malinin VS; Durwas-Krishnan S; Meers P; Perkins WR
J Aerosol Med Pulm Drug Deliv; 2008 Sep; 21(3):245-54. PubMed ID: 18759656
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Comparison of a Vibrating Mesh Nebulizer Operating in Inspiratory Synchronized and Continuous Nebulization Modes During Noninvasive Ventilation.
Michotte JB; Staderini E; Le Pennec D; Dugernier J; Rusu R; Roeseler J; Vecellio L; Liistro G; Reychler G
J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):328-36. PubMed ID: 27310926
[TBL] [Abstract][Full Text] [Related]
4. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
[TBL] [Abstract][Full Text] [Related]
5. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary Drug Delivery Following Continuous Vibrating Mesh Nebulization and Inspiratory Synchronized Vibrating Mesh Nebulization During Noninvasive Ventilation in Healthy Volunteers.
Michotte JB; Staderini E; Aubriot AS; Jossen E; Dugernier J; Liistro G; Reychler G
J Aerosol Med Pulm Drug Deliv; 2018 Feb; 31(1):33-41. PubMed ID: 28683216
[TBL] [Abstract][Full Text] [Related]
7. A randomized double-blind placebo-controlled dose-escalation phase 1 study of aerosolized amikacin and fosfomycin delivered via the PARI investigational eFlow® inline nebulizer system in mechanically ventilated patients.
Montgomery AB; Vallance S; Abuan T; Tservistas M; Davies A
J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):441-8. PubMed ID: 24383962
[TBL] [Abstract][Full Text] [Related]
8. A gamma scintigraphy study to investigate lung deposition and clearance of inhaled amikacin-loaded liposomes in healthy male volunteers.
Weers J; Metzheiser B; Taylor G; Warren S; Meers P; Perkins WR
J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):131-8. PubMed ID: 19422313
[TBL] [Abstract][Full Text] [Related]
9. Changes in performance of the Pari eFlow rapid and Pari LC Plus during 6 months use by CF patients.
Rottier BL; van Erp CJ; Sluyter TS; Heijerman HG; Frijlink HW; Boer AH
J Aerosol Med Pulm Drug Deliv; 2009 Sep; 22(3):263-9. PubMed ID: 19466906
[TBL] [Abstract][Full Text] [Related]
10. Aerosol Production by Vibrating Membrane Technology: Analysis of the Electrolyte Effect on Generated Droplet Size and Nebulizer Output Rate.
Beck-Broichsitter M
J Pharm Sci; 2017 Aug; 106(8):2168-2172. PubMed ID: 28479359
[TBL] [Abstract][Full Text] [Related]
11. Fabrication, characterization and optimization of nanostructured lipid carrier formulations using Beclomethasone dipropionate for pulmonary drug delivery via medical nebulizers.
Khan I; Hussein S; Houacine C; Khan Sadozai S; Islam Y; Bnyan R; Elhissi A; Yousaf S
Int J Pharm; 2021 Apr; 598():120376. PubMed ID: 33617949
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Characterization of the eFlow Closed System Nebulizer with Glycopyrrolate Inhalation Solution.
Pham S; Ferguson GT; Kerwin E; Goodin T; Wheeler A; Bauer A
J Aerosol Med Pulm Drug Deliv; 2018 Jun; 31(3):162-169. PubMed ID: 29125918
[TBL] [Abstract][Full Text] [Related]
13. Effective nebulization of interferon-γ using a novel vibrating mesh.
Sweeney L; McCloskey AP; Higgins G; Ramsey JM; Cryan SA; MacLoughlin R
Respir Res; 2019 Apr; 20(1):66. PubMed ID: 30943978
[TBL] [Abstract][Full Text] [Related]
14. Delivery efficacy of a vibrating mesh nebulizer and a jet nebulizer under different configurations.
Pitance L; Vecellio L; Leal T; Reychler G; Reychler H; Liistro G
J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):389-96. PubMed ID: 20958144
[TBL] [Abstract][Full Text] [Related]
15. Aerosol delivery of recombinant human DNase I: in vitro comparison of a vibrating-mesh nebulizer with a jet nebulizer.
Johnson JC; Waldrep JC; Guo J; Dhand R
Respir Care; 2008 Dec; 53(12):1703-8. PubMed ID: 19025706
[TBL] [Abstract][Full Text] [Related]
16. Nebulization and
Mišík O; Kejíková J; Cejpek O; Malý M; Jugl A; Bělka M; Mravec F; Lízal F
Mol Pharm; 2024 Apr; 21(4):1848-1860. PubMed ID: 38466817
[TBL] [Abstract][Full Text] [Related]
17. Nebulization of liposomal rh-Cu/Zn-SOD with a novel vibrating membrane nebulizer.
Wagner A; Vorauer-Uhl K; Katinger H
J Liposome Res; 2006; 16(2):113-25. PubMed ID: 16753966
[TBL] [Abstract][Full Text] [Related]
18. PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.
Nasr M; Najlah M; D'Emanuele A; Elhissi A
Int J Pharm; 2014 Jan; 461(1-2):242-50. PubMed ID: 24275446
[TBL] [Abstract][Full Text] [Related]
19. Electrolyte type and nozzle composition affect the process of vibrating-membrane nebulization.
Beck-Broichsitter M; Oesterheld N
Eur J Pharm Biopharm; 2017 Oct; 119():11-16. PubMed ID: 28499855
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model.
Sidler-Moix AL; Di Paolo ER; Dolci U; Berger-Gryllaki M; Cotting J; Pannatier A
Respir Care; 2015 Jan; 60(1):38-46. PubMed ID: 25516995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]